Mohammadi Shahrokhi et al. (2018) verified that IL-17A expression deteriorates the AD condition through the induction of Aβ and indicated the important roles of the IL-23/IL-17A axis in the AD pathogenesis. This evidence concerns the gene IL17A and Alzheimer disease.